IJMS | Free Full-Text | Type I Interferon Production of Plasmacytoid Dendritic Cells under Control
Type I interferon in rheumatic diseases | Nature Reviews Rheumatology
Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
Frontiers | Insulin Signaling in Arthritis
Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model | Journal of Translational Medicine | Full Text
Involvement of T helper 1 (Th1) cells in the immune regulation of... | Download Scientific Diagram
Dynamic control of type I IFN signalling by an integrated network of negative regulators: Trends in Immunology
Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases
Cells | Free Full-Text | miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis
IJMS | Free Full-Text | Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
Full article: New insights into IFN-γ in rheumatoid arthritis: role in the era of JAK inhibitors
Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
Frontiers | Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus
Interferon-β for treatment of rheumatoid arthritis? | Arthritis Research & Therapy | Full Text
IJMS | Free Full-Text | Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis
Frontiers | Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis: Trends in Endocrinology & Metabolism
Frontiers | The Molecular Pathophysiology of Psoriatic Arthritis—The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome
Nucleic Acids for Potential Treatment of Rheumatoid Arthritis | ACS Applied Bio Materials
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies | Bone Research
Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses | PLOS Pathogens
Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis
Biomaterial-based immunotherapeutic strategies for rheumatoid arthritis | SpringerLink
